Founded to close Asia’s persistent “drug lag,” Renalys develops innovative therapies for chronic kidney disease across Japan and the region. The company has completed primary endpoint data collection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback